Abstract
Utilizing the polyvinyl sponge-implant model, we have reported in vivo modification of low-density lipoproteins (LDL) isolated from interstitial inflammatory fluid (IF) of the rabbit. Further studies on the metabolism of IF-LDL by resident mouse peritoneal macrophages (MPM), demonstrated enhanced uptake and degradation of these modified lipoproteins by scavenger mechanisms. Based upon these studies, we attempted to examine the mechanisms of these observed in vivo modifications in IF-LDL by in vitro incubation of plasma LDL with inflammatory fluid subfractions. Incubation of LDL with inflammatory cells at 37°C resulted in an increased anodal electrophoretic mobility and alteration in apolipoprotein (APO) composition. Subsequent incubation of this modified plasma LDL with MPM resulted in a significant increase in cell surface binding and an increase in the appearance of degradation products in the medium. The formation of lipid peroxides, measured as thiobarbituric acid-reacting substances (T Bars), increased with the time of LDL incubation with inflammatory cells. Conversely, incubation of LDL with cell-free, lipoprotein-deficient IF (LPDIF,d>1.210 g/ml) significantly inhibited LDL degradation by MPM. LPDIF did not alter the electrophoretic mobility of LDL or result in the appearance of T Bars in the medium. These results implicate peroxidative reactions associated with an inflammatory response as mediators of the in vivo modifications in IF-LDL which facilitates enhanced uptake via the scavenger receptor in MPM.
Similar content being viewed by others
References
Ross, R. 1986. The pathogenesis of atherosclerosis-an update.N. Engl. J. Med. 314:488–500.
Goldstein, J. L., Y. K. Ho, S. K. Basu, andM. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoprotein, producing massive cholesterol deposition.Proc. Natl. Acad. Sci. U.S.A. 76:333–337.
Fogelman, A. M., I. Schechter, J. Seager, M. Hokom, J. S. Child, andP. A. Edwards. 1980. Malondialdehyde alteration of low-density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.Proc. Natl. Acad. Sci. U.S.A. 77:2214–2218.
Valente, A. J., andK. W. Walton. 1984. The binding of acetic anhydride and citraconic anhydride-modified human low-density lipoprotein to mouse peritoneal macrophages. The evidence for separate binding sites.Biochim. Biophys. Acta 792:16–24.
Henriksen, T., E. M. Mahoney, andD. Steinberg. 1983. Enhanced macrophage degradation of biologically modified low-density lipoprotein.Arteriosclerosis 3:149–159.
Raymond, T. L., andS. A. Reynolds. 1983. Lipoproteins of the extravascular space: Alterations in low-density lipoproteins of interstitial inflammatory fluid.J. Lipid Res. 24:113–119.
Raymond, T. L., S. A. Reynolds, andJ. A. Swanson. 1985. Lipoproteins of the extravascular space: Enhanced macrophage degradation of low-density lipoproteins from interstitial inflammatory fluid.J. Lipid Res. 26:1356–1362.
Havel, R. J., H. A. Eder, andJ. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.J. Clin. Invest. 34:1345–1353.
Fraker, P. J., andJ. C. Speck. 1978. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril.Biochem. Biophys. Res. Commun. 80:849–857.
Goldstein, J. L., andM. S. Brown. 1974. Binding and degradation of low density lipoproteins by cultured fibroblasts.J. Biol. Chem. 249:5153–5162.
Henriksen, T., E. M. Mahoney, andD. Steinberg. 1981. Enhanced macrophage degradation of low-density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins.Proc. Natl. Acad. Sci. U.S.A. 78:6499–6503.
Noble, R. P. 1968. Electrophoretic separation of plasma lipoproteins in agarose gel.J. Lipid Res. 9:693–700.
Scanu, A. M., andC. Edelstein. 1971. Solubility in aqueous solutions of ethanol of the small-molecular-weight peptides of the serum very low density and high density lipoproteins: Relevance to the recovery problem during delipidation of serum lipoproteins.Anal. Biochem. 44:576–588.
Lowry, O., N. J. Rosebrouoh, A. L. Farr, andR. J. Randall. 1951. Protein measurement with the Folin phenol reagent.J. Biol. Chem. 193:265–275.
Morel, D. W., J. R. Hessler, andG. M. Chisolm. 1983. Low-density lipoprotein cytotoxicity induced by free radical peroxidation of lipid.J. Lipid Res. 24:1070–1076.
Raymond, T. L., andS. A. Reynolds. 1983. Lipoprotein metabolism in the extravascular space: Leukopenia inhibits modification of low-density lipoproteins in interstitial inflammatory fluid of the rabbit.Inflammation 7:241–246.
Steinbrecher, U. P., S. Parthasarathy, D. S. Leake, J. L. Witztum, andD. Steinberg. 1984. Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.Proc. Natl. Acad. Sci. U.S.A. 81:3883–3887.
Van Hinsbergh, V. W. M., M. Scheffer, L. Havens, andH. J. M. Kempen. 1986. Role of endothelial cells and their products in the modification of low density lipoproteins.Biochim. Biophys. Acta 878:49–64.
Cathcart, M. K., D. W. Morel, andG. M. Chisolm III. 1985. Monocytes and neutrophils oxidize low-density lipoprotein making it cytotoxic.J. Leukocyte Biol. 38:341–350.
Haberland, M. E., andA. M. Fogelman. 1985. Scavenger receptor-mediated recognition of maleyl bovine plasma albumin and the demaleylated protein in human monocyte macrophages.Proc. Natl. Acad. Sci. U.S.A. 82:2693–2697.
Brown, M. S., andJ. L. Goldstein. 1985. Scavenger cell receptor shared.Nature 316:680–681.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Raymond, T.L., Reynolds, S.A. & Swanson, J.A. In vitro incubation of low-density lipoproteins with inflammatory cells causes enhanced degradation by macrophages in culture. Inflammation 11, 335–344 (1987). https://doi.org/10.1007/BF00915837
Issue date:
DOI: https://doi.org/10.1007/BF00915837


